Patients' self-management of adverse events and patient-reported outcomes in advanced renal cell carcinoma treated with targeted therapies: A prospective, longitudinal, observational study.

Sung-Hoo HongHo Seok ChungIll-Young SeoTae Gyun KwonHyeon JeongJae-Il ChungSeung Hyun JeonJae Young ParkHong Koo HaByung-Ha ChungWan SongYoung-Joo KimSang-Hee KimJee-Sun LeeJuneyoung LeeJin-Soo Chung

Published in: Journal of patient-reported outcomes (2022)

Longer treatment duration and improved PROs were observed when advanced RCC patients managed targeted therapy-associated AEs well. Repeated education for consolidating AE self-management could be considered to enhance overall treatment outcomes.

Keyphrases

patient reported outcomes
end stage renal disease
newly diagnosed
renal cell carcinoma
ejection fraction
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
cross sectional
quality improvement